ROS has been identified as an important trigger for NLRP3 inflammasome activation in cardiovascular disease [37], which was further confirmed by immunofluorescent staining that showed CoQ10 treatment significantly suppressed the intracellular ROS production in macrophages both in vivo and ex vivo (Supplemental Fig. 4A-D). Here, NLRP3 is linked to cardiovascular disorder.